Clinical Trial Update: Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating chronic sleep deprivation as a risk factor for metabolic syndrome and obesity has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Obesity, Chronic Sleep Deprivation | Phase 2 | Status: TERMINATED